Transcriptomics identifies blunted immunomodulatory effects of vitamin D in people with multiple sclerosis

Wei Z. Yeh,Rodney Lea,Jim Stankovich,Sandeep Sampangi,Louise Laverick,Anneke Van der Walt,Vilija Jokubaitis,Melissa Gresle,Helmut Butzkueven

DOI: https://doi.org/10.1038/s41598-024-51779-0

IF: 4.6

2024-01-18

Scientific Reports

Abstract:Vitamin D deficiency is a risk factor for developing multiple sclerosis (MS). However, the immune effects of vitamin D in people with MS are not well understood. We analyzed transcriptomic datasets generated by RNA sequencing of immune cell subsets (CD4 + , CD8 + T cells, B cells, monocytes) from 33 healthy controls and 33 untreated MS cases. We utilized a traditional bioinformatic pipeline and weighted gene co-expression network analysis (WGCNA) to determine genes and pathways correlated with endogenous vitamin D. In controls, CD4 + and CD8 + T cells had 1079 and 1188 genes, respectively, whose expressions were correlated with plasma 25-hydroxyvitamin D level ( P < 0.05). Functional enrichment analysis identified association with TNF-alpha and MAPK signaling. In CD4 + T cells of controls, vitamin D level was associated with expression levels of several genes proximal to multiple sclerosis risk loci ( P = 0.01). Genes differentially associated with endogenous vitamin D by case–control status were enriched in TNF-alpha signaling via NF-κB. WGCNA suggested a blunted response to vitamin D in cases relative to controls. Collectively, our findings provide further evidence for the immune effects of vitamin D, and demonstrate a differential immune response to vitamin D in cases relative to controls, highlighting a possible mechanism contributing to MS pathophysiology.

multidisciplinary sciences